Drug Trial Radar · NCT06332014
Evaluation of Efficacy and Safety of Prolia in Subjects of Male Osteoporosis in Mainland China
Last checked: Nov 20, 2026Latest source record: Feb 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
102
Actual
Start
Aug 6, 2024
Primary completion
Jan 23, 2027
Study completion Jan 23, 2027
Sponsor
- Lead sponsor
- AmgenAmgen (AMGN)
- Sponsor type
- Industry
- First posted
- Mar 26, 2024
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- Male only, from 30 years, up to 90 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of this study is to evaluate the efficacy of Prolia on lumbar spine BMD at 12 months.
Conditions
- Osteoporosis
Interventions
ProliaDrug
Partcipants will receive subcutaneous (SC) injections of Prolia Q6M.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent change from baseline in bone mineral density (BMD) of lumbar spine at month 12Time frame: Baseline and Month 12
Locations
16 sites in 1 country. Site status is shown where the registry gives one.
Shanghai Sixth Peoples Hospital
Shanghai, China
Peking University First Hospital
Beijing, Beijing Municipality, China
Beijing Jishuitan Hospital
Beijing, Beijing Municipality, China
The First Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, China
Sun Yat-sen Memorial Hospital Sun Yat-sen University
Guangzhou, Guangdong, China
Nanfang Hospital Southern Medical University
Guangzhou, Guangdong, China
The Fourth Hospital of Harbin Medical University
Harbin, Heilongjiang, China
Huaian First Peoples Hospital
Huaian, Jiangsu, China
The Second Affiliated Hospital of Nanjing Medical University
Nanjing, Jiangsu, China
The First Affiliated Hospital of Soochow University
Suzhou, Jiangsu, China
The First Peoples Hospital of Kunshan
Suzhou, Jiangsu, China
The Affiliated Hospital of Xuzhou Medical University
Xuzhou, Jiangsu, China
Xuzhou Central Hospital
Xuzhou, Jiangsu, China
Jiangxi Provincial Peoples Hospital
Nanchang, Jiangxi, China
Pingxiang Peoples Hospital
Pingxiang, Jiangxi, China
Qilu Hospital of Shandong University
Jinan, Shandong, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.